Monthly Archives: September 2009

Corn Growers Try to Understand Indirect Land Use Change

The National Corn Growers Association’s recent “Land Use: Carbon Impacts of Corn Based Ethanol 2009” conference highlighted the confusion the issue of indirect land use change has engendered for farmers. Chuck Zimmerman of AgWired summed it up in a report from the conference: Do you understand things like indirect land use when it comes to regulations via departments like the EPA due to the RFS? Me either. And I’ve sat in on conferences and discussions Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,

Newron Announces Positive Results for Ralfinamide

Newron Pharmaceuticals SpA, announced positive preclinical study results showing that ralfinamide has statistically significant benefits against spontaneous chronic pain in an experimental model of central pain. Ralfinamide has shown positive results in chronic pain on CNS targets, in addition to its known peripheral mechanisms; Ralfinamide’s unique ability to affect central targets widens its broad spectrum of analgesic mechanisms, supporting its therapeutic potential for alleviating Neuropathic Low Back Pain (NLBP) in the ongoing SERENA Phase IIb/III Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,

Flu Study Finds Only One H1N1 Vaccine Shot Needed

Early results from clinical trials show that the majority of healthy adults may only need one vaccine shot rather than two to protect against the H1N1 virus. Results are showing that the effects of the vaccine are starting faster than expected. Those results could mean that the limited vaccine supply, with an estimated 45 million doses to be made available next month because of poorer-than-expected yields from growing the virus in chicken eggs, could be Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Team at BrainCells using brain cells

An interview with James A. Schoeneck, Chief Executive Officer, BrainCells, Inc.: Can you describe the top priorities or upcoming milestones for your company? BrainCells Inc. has two up-coming milestones in 1Q10: the advancement of BCI-632 into a Phase 1 clinical trial, and Phase 2 data for BCI-540 in patients with treatment resistant depression and anxiety. Both compounds have novel mechanisms of action.  In July, the company announced the outcome of an exploratory Phase 2 study Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,

BIO Salutes Norman E. Borlaug, Father of “Green Revolution”

Nobel Laureate Used Biotechnology and Modern Farming Practices to Combat World Hunger Norman E. Borlaug, American geneticist and plant pathologist who lead a global agricultural transformation through his research and advocacy for modern farming practices, died Saturday, September 12th in Dallas. Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO) issued the following statement in tribute to Dr. Borlaug: “On behalf of BIO and its members, we offer our condolences to the Borlaug Read More >

Farmer Gene  |  1 Comment  |  Email This Post